| Identification | Back Directory | [Name]
Urea, N-[4-[7-[(2,6-difluorophenyl)methyl]-3-[(dimethylamino)methyl]-4,5,6,7-tetrahydro-5-(6-methoxy-3-pyridazinyl)-4,6-dioxo-2H-pyrazolo[3,4-d]pyrimidin-2-yl]phenyl]-N'-methoxy- | [CAS]
1709823-61-9 | [Synonyms]
GnRH antagonist 2
Urea, N-[4-[7-[(2,6-difluorophenyl)methyl]-3-[(dimethylamino)methyl]-4,5,6,7-tetrahydro-5-(6-methoxy-3-pyridazinyl)-4,6-dioxo-2H-pyrazolo[3,4-d]pyrimidin-2-yl]phenyl]-N'-methoxy- | [Molecular Formula]
C28H27F2N9O5 | [MOL File]
1709823-61-9.mol | [Molecular Weight]
607.57 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 150 mg/mL (246.89 mM; ultrasonic and warming and heat to 60°C) | [form ]
Solid | [color ]
White to yellow |
| Hazard Information | Back Directory | [Biological Activity]
GnRH antagonist 2 (formula I) is a GnRH receptor antagonist that can be used for endometriosis research[1]. | [References]
[1]. Quanliang Zhang, et al. Crystalline form of gnrh receptor antagonist and preparation method therefor. WO2018086608A1. |
|
|